Contained in that interview are the exact reasons why the FDA will most likely never give GenViro serious consideration. I’ve said many times that these tests would require an antibody or antigen component to be viable.. when the axe falls, KB can actually say that he told you so. Brutal.
(0)
(3)
Decision Diagnostics Corp (DECN) Stock Research Links